Biomedical HIV prevention-and social science

Lancet

Volumn 370, Issue 9581, 2007, Pages 10-11

  Imrie, John ^a   Elford, Jonathan ^b   Kippax, Susan ^a   Hart, Graham J ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CITY UNIVERSITY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUSTRALIA; CIRCUMCISION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUAL; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SOCIOLOGY; VIRUS TRANSMISSION;

EID: 34347396775     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61026-5     Document Type: Note

References (11)

1. Gray R., Kigozi G., Serwadda D., et al. Male circumcision for HIV prevention in men in Rakia, Uganda: a randomised trial. Lancet 369 (2007) 657-666
2. Bailey R., Moses S., Parker C., et al. Male circumcision in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369 (2007) 343-356
3. Global Campaign for Microbicides. Cellulose sulfate trials close. http://www.global-campaign.org/cellulose-sulfate.htm (accessed June 28, 2007).
4. UNAIDS/WHO. WHO and UNAIDS announce recommendations from expert meeting on male circumcision for HIV prevention (March 28, 2007). http://data.unaids.org/pub/PressRelease/2007/20070328_pr_mc_recommendati ons_en.pdf (accessed June 18, 2007).
5. Peterson L., Taylor D., Roddy R., et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blinded placebo controlled trial. PLoS Clin Trials (May, 2007). http://clinicaltrials.plosjournals.org/archive/1555-5887/2/5/pdf/ 10.1371_journal.pctr.0020027-L.pdf http://clinicaltrials.plosjournals.org/archive/1555-5887/2/5/pdf/ 10.1371_journal.pctr.0020027-L.pdf (accessed June 18, 2007).
6. Bansa E. Studies on circumcision, AIDS suspect. East African Standard (Feb 28, 2007). http://www.eastandard.net/archives/index.php?mnu=details&id=11439654 25&catid=17&PHPSESSID=75a1e1ee5c1e76e716011de19202a2b4 (accessed June, 2007).
7. Ayodo H. Luo elders reject male circumcision. East African Standard (March 31, 2007). http://www.eastandard.net/archives/index.php?mnu=details&id=11439667 30&catid=159 (accessed June, 2007).
8. Foss A., Vickerman P., Heise L., and Watts C. Shifts in condom use following microbicide introduction: should we be concerned?. AIDS 17 (2003) 1227-1237
9. Cassell M., Halperin D., Shelton J., and Stanton D. Risk compensation: the Achilles' heel of innovation in HIV prevention. BMJ 332 (2006) 605-607
10. Truong H.-H., Kellogg T., Klausner J., et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting?. Sex Transm Infect 82 (2006) 461-466
11. Crepaz N., Hart T., and Marks G. Highly active antiretroviral therapy and sexual risk behaviour: a meta-analytic review. JAMA 292 (2004) 224-236